BTL-TML

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameBTL-TML
Drug Alias NameBTL-TML-HSVBTL TML001BTL-TML001BTL-TML-001BTL-TML-COVID
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein biosynthesis inhibitorsTubulin polymerisation inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Stomatitis, Herpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBeech Tree Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeech Tree Labs Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Stomatitis, Herpetic

Other Information

ATC CodeN/A
Related LinksN/A